Microbiotica Email Format
Biotechnology ResearchEngland, United Kingdom51-200 Employees
Microbiotica is a biotechnology research company focused on microbiome science, linking analysis of gut microbiota to patient phenotypes. It specializes in gut bacterial culturing and maintains a microbiome culture collection and a proprietary reference genome database, supported by advanced microbiome bioinformatics. The company also pursues microbiome-host biology and preclinical development of bacterial products, with a pipeline of live bacterial therapeutics and biomarkers for inflammatory bowel disease, immuno-oncology, and gut epithelial barrier repair. Based in Little Chesterford, England, Microbiotica operates as a mid-sized biotechnology company. It collaborates with Cancer Research UK and Cambridge University Hospitals in immuno-oncology, Genentech/Roche in IBD, and the University of Adelaide in ulcerative colitis. In June 2025, the company announced the appointment of Dr. Robert Tansley as Chief Medical Officer.